Cidara Therapeutics Inc (NASDAQ:CDTX)

2.04
BATS BZX Real-Time Price
As of 11:45am ET
 +0.02 / +0.99%
Today’s Change
1.82
Today|||52-Week Range
4.45
+2.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$107.7M

Company Description

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Contact Information

Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive
San Diego California 92121
P:(858) 752-6170
Investor Relations:

Employees

Shareholders

Individual stakeholders29.41%
Other institutional28.49%
Mutual fund holders12.89%

Top Executives

Jeffrey L. SteinPresident, Chief Executive Officer & Director
Paul DaruwalaChief Operating Officer
James E. LevineChief Financial Officer
Les TariSenior Vice President-Research
Taylor SandisonChief Medical Officer